Tratamiento del trastorno mixto de ansiedad-depresión con sertralina

Actas Espanolas de Psiquiatria

Volumn 25, Issue 3, 1997, Pages 141-145

  Carrasco, José Luis ^a,c   Díaz Marsá, Marina ^b   Sáiz, Jerónimo ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Anxiety; Depression; Mixed anxiety and depression disorder; Sertraline; SSRI; Treatment

Indexed keywords

1 NAPHTHYLAMINE; ANTIDEPRESSANT AGENT; DRUG DERIVATIVE; SERTRALINE;

ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; MALE; PSYCHOLOGICAL RATING SCALE;

1-NAPHTHYLAMINE; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SERTRALINE;

EID: 2742588184     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. a edición. Ginebra, 1992.
2. a edición. Washington, 1994.
3. Von Korff M, Shapiro S, Burke JD, Teitlebaum M, Skinner EA, German P, Turner RW, Klein L, Burns B. Anxiety and depression in a primary care clinic: comparison of Diagnostic Interview Schedule, General Health Questionnaire and practitioner assesments. Arch Gen Psychiatry 1987;44:152-6.
4. Zinbarg R, Barlow DH. Mixed anxiety-depression: a new diagnostic category? En Rapee RM, Barlow DH, editores. Chronic Anxiety: Generalized Anxiety Disorder and Mixed Anxiety-Depression. New York: Guilford Press, 1991.
5. Kahn RJ, McNair DM, Frankenthaler LM. Tryciclic treatment of generalized anxiety disorder. Special issue: drug treatment of anxiety disorders. J Affective Disord 1987;13(2):145-51.
6. Filteau MJ, Baruch P, Lapierre YD. SSRI in anxious-agitated deoression: a post-hoc analysis of 279 patients. Int Clin Psychopharmacol 1995;10:51-4.
7. Jefferson JW. Antidepressants in panic disorder. J Clin Psychiatry 1997;58 (suppl 2):20-4.
8. Germine M, Goddard AW, Woods SW, Charney DS, Heninger GR. Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder. Biol Psychiatry 1992;32:457-61.
9. Laws D, Ashford JJ, Anstee JA. A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice. Acta Psychiatrica Scand 1990;81: 185-9.
10. Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, et al. The DSM-IV Field Trial for Mixed Anxiety-Depression. Am J Psychiatry 1994;151,8: 1153-62.
11. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnormam Psychol 1991;100:316-36.
12. Cornelius JR, Soloff PH, Perel JM. Fluoxetine trail in borderline personality disorder. Psychopharmacol Bull 1990;26;151-4.
13. Carrasco JL, Sáiz J, César J, Hollander E, López Ibor JJ. Low Platelet Monoamineoxidase in Pathological Gambling. Acta Psychiat Scandinavia 1994;90:427-31.